Citation: Bd. Hock et al., A soluble form of CD83 is released from activated dendritic cells and B lymphocytes, and is detectable in normal human sera, INT IMMUNOL, 13(7), 2001, pp. 959-967
Authors:
Ho, CSK
Lopez, JA
Vuckovic, S
Pyke, CM
Hockey, RL
Hart, DNJ
Citation: Csk. Ho et al., Surgical and physical stress increases circulating blood dendritic cell counts independently of monocyte counts, BLOOD, 98(1), 2001, pp. 140-145
Authors:
Vuckovic, S
Florin, THJ
Khalil, D
Zhang, MF
Patel, K
Hamilton, I
Hart, DNJ
Citation: S. Vuckovic et al., CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases, AM J GASTRO, 96(10), 2001, pp. 2946-2956
Authors:
Clark, GJ
Cooper, B
Fitzpatrick, S
Green, B
Hart, DNJ
Citation: Gj. Clark et al., The gene encoding the immunoregulatory signaling molecule CMRF-35A localized to human chromosome 17 in close proximity to other members of the CMRF-35 family, TISSUE ANTI, 57(5), 2001, pp. 415-423
Authors:
Kato, M
Neil, TK
Fearnley, DB
McLellan, AD
Vuckovic, S
Hart, DNJ
Citation: M. Kato et al., Expression of multilectin receptors and comparative FITC-dextran uptake byhuman dendritic cells, INT IMMUNOL, 12(11), 2000, pp. 1511-1519
Authors:
Snowden, JA
Hill, GR
Hunt, P
Carnoutsos, S
Spearing, RL
Espiner, E
Hart, DNJ
Citation: Ja. Snowden et al., Assessment of cardiotoxicity during haemopoietic stem cell transplantationwith plasma brain natriuretic peptide, BONE MAR TR, 26(3), 2000, pp. 309-313
Authors:
MacLean, FR
Hanley, JP
Patton, WN
Hart, DNJ
Langley, S
Bayston, K
Jeffery, GM
Citation: Fr. Maclean et al., Successful high dose therapy for relapsed mediastinal large B cell lymphoma following surgical repair of anterior chest wall defect, CLIN LAB H, 22(2), 2000, pp. 127-128
Authors:
El Sherbini, H
Hock, B
Fearnley, D
McLellan, A
Vuckovic, S
Hart, DNJ
Citation: H. El Sherbini et al., Lectin ligands on human dendritic cells and identification of a peanut agglutinin positive subset in blood, CELL IMMUN, 200(1), 2000, pp. 36-44
Citation: Gj. Clark et al., The CMRF-35H gene structure predicts for an independently expressed memberof an ITIM/ITAM pair of molecules localized to human chromosome 17, TISSUE ANTI, 55(2), 2000, pp. 101-109
Citation: Dnj. Hart et Gr. Hill, Dendritic cell immunotherapy for cancer: Application to low-grade lymphomaand multiple myeloma, IMM CELL B, 77(5), 1999, pp. 451-459
Authors:
Troy, AJ
Davidson, PJT
Atkinson, CH
Hart, DNJ
Citation: Aj. Troy et al., CD1A dendritic cells predominate in transitional cell carcinoma of bladderand kidney but are minimally activated, J UROL, 161(6), 1999, pp. 1962-1967
Citation: Ad. Mclellan et al., Induction of dendritic cell costimulator molecule expression is suppressedby T cells in the absence of antigen-specific signalling: role of cluster formation, CD40 and HLA-class II for dendritic cell activation, IMMUNOLOGY, 98(2), 1999, pp. 171-180
Authors:
Clark, GJ
Gunningham, S
Troy, A
Vuckovic, S
Hart, DNJ
Citation: Gj. Clark et al., Expression of the RelB transcription factor correlates with the activationof human dendritic cells, IMMUNOLOGY, 98(2), 1999, pp. 189-196
Authors:
Fearnley, DB
Whyte, LF
Carnoutsos, SA
Cook, AH
Hart, DNJ
Citation: Db. Fearnley et al., Monitoring human blood dendritic cell numbers in normal individuals and instem cell transplantation, BLOOD, 93(2), 1999, pp. 728-736
Authors:
Hock, BD
Fearnley, DB
Boyce, A
McLellan, AD
Sorg, RV
Summers, KL
Hart, DNJ
Citation: Bd. Hock et al., Human dendritic cells express a 95 kDa activation/differentiation antigen defined by CMRF-56, TISSUE ANTI, 53(4), 1999, pp. 320-334